A Phase II Trial of Androgen Suppression and Radiation Therapy with Samarium-153 in Localized, High-Risk, Prostate Cancer

Stereotactic Body Radiation Therapy for Unfavorable Intermediate- and High-Risk Prostate Cancer: 3-Year Outcomes of a Phase II Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.06.269 ◽

2018 ◽

Vol 102 (3) ◽

pp. S105-S106

Author(s):

V.A. Macias-Hernandez ◽

I. Barrera-Mellado ◽

C. Marti ◽

A. Pont ◽

A. Fernandez-Lara ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii ◽

Stereotactic Body Radiation Therapy ◽

Phase Ii Trial ◽

Stereotactic Body Radiation ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

Ultra-hypofractionated radiation therapy for unfavourable intermediate-risk and high-risk prostate cancer is safe and effective: 5-year outcomes of a phase II trial

BJU International ◽

10.1111/bju.14925 ◽

2019 ◽

Vol 125 (2) ◽

pp. 215-225

Author(s):

Victor A. Macias ◽

Inmaculada Barrera-Mellado

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii ◽

Phase Ii Trial ◽

Intermediate Risk ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Hypofractionated Radiation Therapy ◽

Hypofractionated Radiation

Download Full-text

Patient-Reported QOL Outcomes of Hypofractionated Stereotactic Body Radiation Therapy Boost for the Treatment of Localized, Non-Metastatic, High-Risk Prostate Cancer: Updated Results of a Phase II Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.533 ◽

2020 ◽

Vol 108 (3) ◽

pp. e907-e908

Author(s):

K. Cheng ◽

M.M. Qureshi ◽

M.A. Dyer ◽

B.N. Bloch ◽

G. Gignac ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii ◽

Stereotactic Body Radiation Therapy ◽

Phase Ii Trial ◽

Stereotactic Body Radiation ◽

High Risk Prostate Cancer ◽

Patient Reported ◽

Risk Prostate Cancer

Download Full-text

Concurrent and adjuvant docetaxel with three-dimensional conformal radiation therapy plus androgen deprivation for high-risk prostate cancer: Preliminary results of a multicentre phase II trial

Radiotherapy and Oncology ◽

10.1016/j.radonc.2010.08.012 ◽

2010 ◽

Vol 97 (2) ◽

pp. 312-317 ◽

Cited By ~ 23

Author(s):

Michel Bolla ◽

Jean Michel Hannoun-Levi ◽

Jean-Marc Ferrero ◽

Philippe Maingon ◽

Joëlle Buffet-Miny ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii ◽

Phase Ii Trial ◽

Three Dimensional ◽

Conformal Radiation Therapy ◽

Multicentre Phase ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text

Neoadjuvant apalutamide (arn-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) – initial results of a phase II trial

European Urology Supplements ◽

10.1016/s1569-9056(19)31008-5 ◽

2019 ◽

Vol 18 (1) ◽

pp. e1394

Author(s):

E.J. Aslim ◽

X. Yang ◽

N-T. Ngo ◽

L.Y. Khor ◽

K. Chen ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Phase Ii ◽

Phase Ii Trial ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Initial Results

Download Full-text

A phase III protocol of androgen suppression (AS) and radiation therapy (RT) versus AS and RT followed by chemotherapy with paclitaxel, estramustine, and etoposide (TEE) for localized, high-risk, prostate cancer, RTOG 9902.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4632 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4632-4632 ◽

Cited By ~ 3

Author(s):

H. M. Sandler ◽

D. Hunt ◽

A. O. Sartor ◽

L. G. Gomella ◽

A. Hartford ◽

...

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Iii ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Androgen Suppression

Download Full-text

A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity

Frontiers in Oncology ◽

10.3389/fonc.2014.00336 ◽

2014 ◽

Vol 4 ◽

Cited By ~ 11

Author(s):

Victor A. Macias ◽

Manuel L. Blanco ◽

Inmaculada Barrera ◽

Rafael Garcia

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Phase Ii ◽

Stereotactic Body Radiation Therapy ◽

Helical Tomotherapy ◽

Phase Ii Study ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Early Toxicity

Download Full-text

Radiation Therapy Oncology Group 0521: A Phase III Randomized Trial of Androgen Suppression and Radiation Therapy Versus Androgen Suppression and Radiation Therapy Followed by Docetaxel/Prednisone for Localized, High-Risk Prostate Cancer

Clinical Genitourinary Cancer ◽

10.3816/cgc.2005.n.035 ◽

2005 ◽

Vol 4 (3) ◽

pp. 212-214 ◽

Cited By ~ 15

Author(s):

Asmita R. Patel ◽

Howard M. Sandler ◽

Kenneth J. Pienta

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Randomized Trial ◽

Radiation Therapy Oncology Group ◽

Phase Iii ◽

Oncology Group ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Androgen Suppression

Download Full-text

Acute and late toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated pelvic radiation therapy

Practical Radiation Oncology ◽

10.1016/j.prro.2017.01.003 ◽

2017 ◽

Vol 7 (4) ◽

pp. 264-269 ◽

Cited By ~ 5

Author(s):

Sergio Faria ◽

Russel Ruo ◽

Fabio Cury ◽

Marie Duclos ◽

Luis Souhami

Keyword(s):

Prostate Cancer ◽

Radiation Therapy ◽

High Risk ◽

Cancer Patients ◽

Late Toxicity ◽

Pelvic Radiation ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer ◽

Androgen Suppression

Download Full-text

Neoadjuvant IMC-A12 and combined androgen deprivation with prostatectomy for high-risk prostate cancer: A phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps251 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS251-TPS251 ◽

Cited By ~ 3

Author(s):

J. P. Dean ◽

S. R. Plymate ◽

B. L. Dalkin ◽

W. J. Ellis ◽

D. W. Lin ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Phase Ii ◽

Phase Ii Trial ◽

Androgen Deprivation ◽

High Risk Prostate Cancer ◽

Risk Prostate Cancer

Download Full-text